
Sign up to save your podcasts
Or


This is the latest episode of the free DDW narrated podcast, titled "The revolutionary impact of understanding genomics", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "Open science, genomics, and the quiet revolution in our approach to pharma" and "Junk DNA: How the dark genome is changing RNA therapies".
In the first article, Evan Floden, CEO of Seqera Labs, examines how data sharing platforms are impacting cancer and genomics research.
In the second article, Samir Ounzain, CEO & Co-Founder of HAYA Therapeutics, looks at how a better understanding of our DNA can lead to increased activity for RNA therapeutics.
By Drug Discovery World (DDW)3.5
2020 ratings
This is the latest episode of the free DDW narrated podcast, titled "The revolutionary impact of understanding genomics", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "Open science, genomics, and the quiet revolution in our approach to pharma" and "Junk DNA: How the dark genome is changing RNA therapies".
In the first article, Evan Floden, CEO of Seqera Labs, examines how data sharing platforms are impacting cancer and genomics research.
In the second article, Samir Ounzain, CEO & Co-Founder of HAYA Therapeutics, looks at how a better understanding of our DNA can lead to increased activity for RNA therapeutics.

43,615 Listeners

7,589 Listeners

4,150 Listeners

761 Listeners

162 Listeners

404 Listeners

823 Listeners

112,031 Listeners

56,537 Listeners

320 Listeners

640 Listeners

66 Listeners

787 Listeners

86 Listeners

20 Listeners